A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
This study has been completed.
Study NCT00002199.
Last updated on June 23, 2005.
Information provided by NIH AIDS Clinical Trials Information Service
Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study: